Cargando…
Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients
BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentatio...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726865/ https://www.ncbi.nlm.nih.gov/pubmed/33303010 http://dx.doi.org/10.1186/s13075-020-02365-y |
_version_ | 1783620967602323456 |
---|---|
author | Li, Jing Wang, Yahong Wang, Yanhong Wang, Ying Yang, Yunjiao Zhao, Jiuliang Li, Mengtao Tian, Xinping Zeng, Xiaofeng |
author_facet | Li, Jing Wang, Yahong Wang, Yanhong Wang, Ying Yang, Yunjiao Zhao, Jiuliang Li, Mengtao Tian, Xinping Zeng, Xiaofeng |
author_sort | Li, Jing |
collection | PubMed |
description | BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentation rate (ESR), serum levels of high-sensitive C-reactive protein (hsCRP), interleukin-6(IL-6), and tumor necrosis factor-α (TNFα) and disease activity were analyzed by logistic regression and survival analysis. Kaplan-Meier method was used to estimate the cumulative remission rate curve, log-rank tests for group comparison, and Cox regression for estimating hazard ratios of these parameters for disease activity. RESULTS: 428 patients were included. 188 patients were in active disease, and 240 patients were in inactive disease at baseline. Elevation of ESR, hsCRP, and IL-6 were associated with active disease at baseline and during follow-up. Cox regression and Kaplan-Meier analysis showed that lower possibility and longer time to remission were associated with elevated ESR (hazard ratio [HR] = 0.32, 80 vs 33 weeks, p < 0.001), hsCRP (HR = 0.45, 70 vs 31 weeks, p < 0.001), and IL-6 (HR = 0.54, 66 vs 34 weeks, p < 0.01) in patients with active disease at baseline, while higher risk and shorter time for relapse were associated with elevated ESR (HR = 2.1, 59 vs 111 weeks, p < 0.001), hsCRP (HR = 2.1, 79 vs 113 weeks, p < 0.001), IL-6 (HR = 2.5, 64 vs 117 weeks, p < 0.001), and TNFα (HR = 2.7, 65 vs 114 weeks, p < 0.001) in patients with inactive disease at baseline. CONCLUSIONS: Elevated ESR, CRP, and IL-6 are associated with active disease, lower possibility, and longer time to achieve disease remission. Elevation of any among ESR, CRP, IL-6, and TNFα is associated with high risk and short time for relapse during follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-020-02365-y. |
format | Online Article Text |
id | pubmed-7726865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77268652020-12-10 Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients Li, Jing Wang, Yahong Wang, Yanhong Wang, Ying Yang, Yunjiao Zhao, Jiuliang Li, Mengtao Tian, Xinping Zeng, Xiaofeng Arthritis Res Ther Research Article BACKGROUND: To investigate the association between blood biomarkers and disease activity of Takayasu’s arteritis (TAK) in a follow-up cohort. METHODS: Disease activity was assessed by clinical manifestations and repeated vascular Doppler examinations. The association between erythrocyte sedimentation rate (ESR), serum levels of high-sensitive C-reactive protein (hsCRP), interleukin-6(IL-6), and tumor necrosis factor-α (TNFα) and disease activity were analyzed by logistic regression and survival analysis. Kaplan-Meier method was used to estimate the cumulative remission rate curve, log-rank tests for group comparison, and Cox regression for estimating hazard ratios of these parameters for disease activity. RESULTS: 428 patients were included. 188 patients were in active disease, and 240 patients were in inactive disease at baseline. Elevation of ESR, hsCRP, and IL-6 were associated with active disease at baseline and during follow-up. Cox regression and Kaplan-Meier analysis showed that lower possibility and longer time to remission were associated with elevated ESR (hazard ratio [HR] = 0.32, 80 vs 33 weeks, p < 0.001), hsCRP (HR = 0.45, 70 vs 31 weeks, p < 0.001), and IL-6 (HR = 0.54, 66 vs 34 weeks, p < 0.01) in patients with active disease at baseline, while higher risk and shorter time for relapse were associated with elevated ESR (HR = 2.1, 59 vs 111 weeks, p < 0.001), hsCRP (HR = 2.1, 79 vs 113 weeks, p < 0.001), IL-6 (HR = 2.5, 64 vs 117 weeks, p < 0.001), and TNFα (HR = 2.7, 65 vs 114 weeks, p < 0.001) in patients with inactive disease at baseline. CONCLUSIONS: Elevated ESR, CRP, and IL-6 are associated with active disease, lower possibility, and longer time to achieve disease remission. Elevation of any among ESR, CRP, IL-6, and TNFα is associated with high risk and short time for relapse during follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-020-02365-y. BioMed Central 2020-12-10 2020 /pmc/articles/PMC7726865/ /pubmed/33303010 http://dx.doi.org/10.1186/s13075-020-02365-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Li, Jing Wang, Yahong Wang, Yanhong Wang, Ying Yang, Yunjiao Zhao, Jiuliang Li, Mengtao Tian, Xinping Zeng, Xiaofeng Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title | Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title_full | Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title_fullStr | Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title_full_unstemmed | Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title_short | Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu’s arteritis patients |
title_sort | association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in takayasu’s arteritis patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726865/ https://www.ncbi.nlm.nih.gov/pubmed/33303010 http://dx.doi.org/10.1186/s13075-020-02365-y |
work_keys_str_mv | AT lijing associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT wangyahong associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT wangyanhong associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT wangying associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT yangyunjiao associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT zhaojiuliang associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT limengtao associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT tianxinping associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients AT zengxiaofeng associationbetweenacutephasereactantsinterleukin6tumornecrosisfactoraanddiseaseactivityintakayasusarteritispatients |